Centralized Clinical Pharmacy-Live Drug Order Verifications in Max Hospitals

Situation Prior to Intervention (Baseline Scenario)

Before implementation of the Centralized Prescription Audit system across the hospital network, prescription review and medication verification activities were primarily managed at individual unit levels. This decentralized approach resulted in variations in prescription review practices, inconsistent monitoring of medication-related interventions, and limited visibility of prescribing trends across units.

Several challenges were identified during baseline assessment:

• Lack of a standardized prescription audit process across all units, leading to variation in review practices.

• Limited monitoring of high-risk medication usage, including restricted antibiotics, and high-alert medications.

• Difficulty in identifying prescribing errors in real time, resulting in delayed clinical interventions.

• Absence of centralized data analytics for tracking prescribing trends, medication errors, and intervention outcomes across the organization.

• Inconsistent documentation of pharmacist interventions, making organization-wide quality monitoring difficult.

Baseline Data Observed (Pre-Intervention):

• Prescription audit activities were being performed independently by unit-based teams without centralized monitoring.

• Limited capability to generate consolidated reports for prescription review trends across multiple hospital units.

• Delayed identification and escalation of prescribing errors requiring clinical pharmacist intervention.

• Variability in antibiotic stewardship monitoring due to non-uniform audit processes.

These gaps highlighted the need for a centralized prescription audit

Outcomes Achieved After Intervention

Following implementation of the Centralized Prescription Audit system, the organization established a real-time and continuous prescription monitoring framework across hospital units, significantly strengthening medication safety practices and standardization of clinical pharmacy operations. The intervention enabled live monitoring of prescription-related activities and immediate identification of prescribing discrepancies requiring clinical intervention.

Specific Outcomes Achieved:

• Implementation of a live centralized prescription audit system for continuous monitoring of prescription orders across all covered hospital units.

• Real-time identification and intervention in prescription-related discrepancies, including incorrect dose, frequency errors, therapeutic duplication, contraindications, and incomplete medication orders.

• Standardization of prescription verification and audit practices across all units under a single centralized clinical pharmacy monitoring framework.

• Continuous live monitoring of restricted antibiotic usage, strengthening the Antibiotic Stewardship Program and improving compliance tracking.

• Faster escalation and closure of medication-related interventions due to centralized real-time monitoring by the Central Clinical pharmacy team.

To strengthen medication safety and standardize prescription review practices across the organization, a Centralized Prescription Audit system was implemented under the Central Clinical Pharmacy framework. The initiative was planned after identifying variability in prescription audit practices across individual units and the need for organization-wide monitoring of medication-related interventions. The implementation involved assessment of the existing decentralized prescription review process, identification of key audit parameters such as dose appropriateness, drug interactions, therapeutic duplication, restricted antibiotic monitoring, and development of a centralized workflow through the CPRS platform. The Central Clinical Pharmacy team was assigned responsibility for live prescription monitoring and intervention management.

The intervention was implemented in coordination with hospital leadership, pharmacy management, unit stakeholders, and IT teams to ensure smooth integration with existing workflows. Major workflow changes included shifting prescription audit activities from unit-level review to centralized monitoring, implementation of real-time prescription verification, standardized intervention documentation, and centralized monthly reporting.

This innovation established a continuous live monitoring system, improving standardization, early identification of prescribing errors, antibiotic stewardship monitoring, and organization-wide medication safety oversight in alignment with NABH quality standards.

Prior to implementation of the Centralized Prescription Audit system, prescription review activities were decentralized with limited monitoring coverage and inconsistent identification of prescription-related discrepancies across hospital units. Following implementation, a live centralized prescription audit framework was established under the Central Clinical Pharmacy team.

Performance evaluation was conducted over a period of 5 months (January 2026 to May 2026). During this period, the scope of implementation expanded from 5 hospital units to 7 units, demonstrating successful scale-up of the intervention. Total drug orders monitored increased from 312,351 in January 2026 to 388,923 in May 2026, reflecting a 24.5% increase in prescription audit coverage. Prescription-related discrepancies identified increased from 3,233 cases in January to 5,763 cases in May, representing a 78.2% increase in detection and intervention opportunities through enhanced live monitoring.

The intervention significantly improved real-time prescription surveillance, strengthened medication safety oversight, enhanced early identification of prescribing errors, standardized prescription review practices across units, and improved operational efficiency through centralized monitoring.

Overall, the initiative strengthened patient safety systems and established a sustainable organization-wide quality improvement framework aligned with NABH standards.

Implementation of the Centralized Prescription Audit system involved multiple operational and infrastructural challenges during the transition from decentralized unit-level prescription review to a centralized monitoring model. Major challenges included identification of appropriate centralized workspace, establishment of required IT infrastructure, system access configuration, ensuring uninterrupted phone and communication connectivity with hospital units, and integration of workflow with existing CPRS processes.

Additional challenges included recruitment and onboarding of trained clinical pharmacy staff, allocation of adequate manpower for continuous prescription monitoring, creation of an appropriate office environment to support uninterrupted operations, and coordination with multiple hospital units for smooth operational alignment. Logistic planning was also required for system setup, workstation availability, internet connectivity, and process standardization across units.

The success of the initiative was primarily driven by strong leadership support, organizational commitment toward medication safety, collaboration between pharmacy, IT, and hospital operations teams, timely resource allocation, structured staff training, and development of standardized operating workflows. These institutional factors enabled successful establishment of a sustainable centralized prescription audit model, strengthening patient safety systems and

Implementation of the Centralized Prescription Audit system demonstrated that a centralized clinical pharmacy model significantly improves medication safety by enabling standardized prescription review and continuous live monitoring across multiple hospital units. The initiative highlighted the importance of uniform audit parameters and centralized oversight in reducing variability in prescription review practices and improving organization-wide quality monitoring.

A major learning was that successful implementation of such a model requires strong technology integration, adequate infrastructure planning, trained manpower, reliable communication systems, and close coordination between pharmacy, IT, and operations teams. The intervention also established that centralized monitoring improves early identification of prescribing discrepancies, strengthens antibiotic stewardship practices, enhances documentation of pharmacist interventions, and provides better visibility of prescribing trends.

Overall, the project demonstrated that centralized prescription audit is a scalable and sustainable patient safety initiative supporting continuous quality improvement aligned with NABH standards.